NEUCHATEL, Switzerland & SHENZHEN, China--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) and Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (SZSE: 300760) announced today that they have entered into a ...

Mindray Medical ($MR) and Masimo ($MASI) are laying their years-long legal battle over pulse oximeter technology to rest, with the companies agreeing to dismiss all ...

SHENZHEN, China, Nov. 20, 2015 /PRNewswire/ -- Mindray Medical International Limited (the "Company", NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced ...

Mindray Medical International Limited MR and Masimo Corporation MASI recently agreed to settle and dismiss their patent, contract and anti-trust claims in the U.S. and China. They also agreed not to ...

Improved SpO 2 Accuracy Now Available for All Patient Populations IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today that RD SET ® sensors with Masimo Measure-through Motion and ...

Manufacturer of patient monitoring products, Masimo Corp. ( MASI) recently announced Food and Drug Administration (FDA)'s clearance of the company's Radius-7 wireless monitor, under section 510(k).

With the invention of Signal Extraction Technology ® (SET ®), Masimo established a new standard for pulse oximetry by introducing the ability to measure through motion and low perfusion. In a study ...

Mindray is a leading global provider of medical devices and solutions. Mindray's products and services can be found in healthcare facilities in over 190 countries, and over 1.1 million Mindray ...